Abstract
Vasodilating actions of sinomenine were examined using rat aorta ring strips. Sinomenine (0.1 to 100 microM) dilated norepinephrine (NE, 5 microM)-induced vasoconstriction in a concentration-dependent manner reaching 68.8+/-5.1% (n=6, P<0.01) at a concentration of 100 microM. Sinomenine (100 microM) also attenuated KCl (60 mM) and phorbol 12, 13-dibutyrate (PDB, a protein kinase C, PK-C, activator, 300 nM)-induced vasoconstriction by 86.9+/-8.5% (n=6, P<0.01) and 49.9+/-9.8% (n=6, P<0.01), respectively. Pretreatment with nicardipine (a Ca2+ channel antagonist), staurosporine (a PK-C inhibitor), NG-monomethyl-L-arginine acetate (L-NMMA, a nitric oxide, NO, synthesis inhibitor), and indomethacin (a cyclooxygenase inhibitor) were carried out. Nicardipine (0.1 microM) led to a significant decrease in the vasodilating potential of sinomenine (at 100 microM, 68.8+/-5.1% vs. 35.5+/-6.9%; n=5, P<0.001). Pretreatment with staurosporine (30 nM) reduced sinomenine-associated vasodilation from 68.8+/-5.1% to 49.5+/-7.7% (n=5, P<0.001), and L-NMMA (100 microM) and indomethacin (10 microM), to 25.3+/-2.3% (n=5, P<0.001) and to 37.1+/-9.3% (n=5, P<0.001), respectively. The responses were almost similar to the results without endothelium. Ther...Continue Reading
References
Oct 1, 1990·British Journal of Pharmacology·P Lopez-JaramilloS Moncada
Jan 1, 1987·The Journal of Membrane Biology·H FichtnerM Kohlhardt
Mar 1, 1995·General Pharmacology·H Satoh, N Sperelakis
Aug 1, 1994·International Journal of Immunopharmacology·L LiuV Kaever
Mar 1, 1996·General Pharmacology·H Satoh
Oct 1, 1996·International Journal of Immunopharmacology·L LiuR W Kinne
Apr 2, 1998·General Pharmacology·H Satoh, N Sperelakis
Jun 16, 1999·British Journal of Pharmacology·J F QuignardP M Vanhoutte
Jul 27, 2001·European Journal of Pharmacology·H Satoh
Oct 30, 2001·Life Sciences·Y KubotaM Kunitomo
Apr 4, 2003·Life Sciences·Seiichiro Nishida, Hiroyasu Satoh
Apr 17, 2003·Transplantation·Walter MarkRaimund Margreiter
Jul 23, 2003·Arzneimittel-Forschung·Hiroyasu Satoh
Apr 23, 2005·The American Journal of Chinese Medicine·Wei-Tien ChangZuo-Hui Shao
Dec 16, 2005·The American Journal of Chinese Medicine·Hiroyasu Satoh
Apr 29, 2006·Life Sciences·Seiichiro Nishida, Hiroyasu Satoh
Nov 9, 2006·Planta medica·Huang FengShin Yoshino
Citations
Oct 16, 2012·Molecular and Cellular Biochemistry·Lihua ZhuHong Jiang
Oct 30, 2007·Evidence-based Complementary and Alternative Medicine : ECAM·Seiichiro Nishida, Hiroyasu Satoh
Aug 24, 2007·Clinical and Experimental Pharmacology & Physiology·Ping-Ying LeeJuei-Tang Cheng
Jan 1, 2009·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Hiroyasu Satoh
Nov 15, 2008·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Seiichiro Nishida, Hiroyasu Satoh
Jan 15, 2011·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Hiroyasu Satoh, Seiichiro Nishida
Dec 24, 2013·World Journal of Gastroenterology : WJG·Jing WangShi Qiu
Oct 8, 2013·Bioscience, Biotechnology, and Biochemistry·Ki Hyun KimKang Ro Lee
Jul 11, 2012·Pharmaceutical Biology·Xiang-Xiang ZhaoLu-Ping Qin
Mar 8, 2013·Journal of Integrative Medicine·Hiroyasu Satoh
Nov 8, 2014·Biomedical Chromatography : BMC·Huan YanHua-Lin Cai
Apr 29, 2014·Journal of Ethnopharmacology·Camille DesgrouasEvelyne Ollivier
Apr 29, 2006·Life Sciences·Seiichiro Nishida, Hiroyasu Satoh
Feb 6, 2007·Bioorganic & Medicinal Chemistry Letters·Hongyan DuYalin Tang
May 17, 2019·Phytotherapy Research : PTR·Yang WangHanyang Zhang
Sep 12, 2015·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Hiroyasu Satoh, Seiichiro Nishida